Top Banner
Advanced Injectors Lecture BACD Regional Meeting London June 2008
34

Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Jan 22, 2016

Download

Documents

Daisy Richards
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Advanced Injectors Lecture BACD Regional Meeting

London June 2008

Page 2: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

MEDICAL DISCLOSURE:

Dr. Patrick J. Treacy is a Cosmetic Doctor presently on the Specialist Register in Ireland

He holds a Dip Cos. Med Dip Dermatology, U.K. BTEC Laser Technology

Previously worked in the U. K. U.S. Australia, New Zealand, South Africa.

No financial interest or stock in Bioform nor do I receive any additional remuneration for giving this Advanced Training lecture.

Page 3: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

1. Radiesse XL2. Hand Volumisation

Page 4: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

1. Product Information

2. Injection Techniques

3. What is Beauty?

4. The Aging Face

5. Upper and Mid Face

6. Lower Face

7. 7. HIV Lipodystrophy

PresentationContent

Page 5: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Key Characteristics

• Safe

• Bio-compatible

• Bio-degradable

• Effect 18-24 months

• No migration

• No pre-testing

• No special handling

Page 6: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

CaHA Injectable ImplantKey Components

• Structural component (~30%)• calcium and phosphate ions (Ca10(PO4)6(OH)2)

• natural mineral (identical to human teeth & bone)

• Gel carrier (~70%)• sodium carboxymethylcellulose• glycerine• sterile water

Biocompatible and ‘GRAS’Generally Recognized As Safe by FDA

Page 7: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Uniform sphericalCaHA particles

• Synthetic & pure• consistent, smooth & spherical• 25 to 45 microns

• Size and shape facilitate • ease of injection • tissue infiltration

• Natural mineral • non-antigenic, non-irritant, non-toxic• metabolizes via homeostatic mechanisms

Page 8: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Calcium HydroxylapatiteMetabolisation

CaHA performs as a filler initially.

Page 9: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Calcium HydroxylapatiteMetabolisation

Macrophages dissolve gel carrier.

Page 10: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Calcium HydroxylapatiteMetabolisation

Macrophages dissolve gel carrier & fibroblasts form new collagen.

Page 11: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Calcium HydroxylapatiteMetabolisation

New resident tissue (collagen) anchors microspherules of CaHA.

Page 12: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Calcium HydroxylapatiteMetabolisation

CaHA particles degrade and macrophages metabolize microspherules.

Page 13: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Where is Radiesse Injected?

Mid-Dermis

Deep Dermis

Dermis/SQ Jx.

Sub-QRadiesseSafe Area

Page 14: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Injection technique 1

Inject retrograde in the mid-to-deep dermisnear the junction of the subcutaneous tissue

Miles Graivier, M.D. Roswell, GA.

Page 15: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Injection technique 2

Inject large volumes antegrade in the deep dermis to level of the subcutaneous tissue

Miles Graivier, M.D. Roswell, GA.

Page 16: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Radiesse XL –a novel approach to pain free Radiesse

Page 17: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Most injectors would agree that injectable treatments are better accomplished if the patient is kept comfortable.

This makes the experience more pleasant for the patient which will keep them motivated to return for additional treatments. It also allows the injector to stay more focused on the injection process.

I personally find significant patient discomfort to be a distraction.

Page 18: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Traditional Anesthesia for Radiesse

Most practitioners have typically utilized some form of local anesthesia:– Topical– Infraorbital, mental, supratrochlear, or supraorbital nerve blocks– Local infiltration– Depending upon the physician’s preference, usually 1% to 2%

lidocaine with or without adrenaline is used.

Page 19: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Disadvantage of Topical Agents

The effect of topical agents is mainly limited to the epidermis to upper dermis.

The deep dermis and subdermal tissues are not anesthetized.

The patient still feels the passing of the needle and any discomfort related to the injection of the filler material.

Page 20: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Disadvantages of nerve blocks

May be quite uncomfortable.May cause additional bruising. Depending upon the treatment site, the nerve block

may distort the area to be injected (e.g. the cheek and tear trough with an infraorbital nerve block).

Require some knowledge of the location of key facial foramina to be successful. Therefore, the efficacy of the block may be dependent on the expertise of the injector.

Page 21: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Disadvantages of Local Infiltration

Directly injecting the treatment site distorts the area to be filled and can skew the injector’s judgment as to when optimal filling has been accomplished.

Page 22: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Mixing Lidocaine with Radiesse

Anesthetizes the treatment site as the injection process progresses.

In most cases, the mixing of lidocaine with Radiesse obviates the need for nerve blocks or local infiltration.

Most patients prefer injecting the mixed product to having nerve blocks.

Some patients still will require or desire nerve blocks (sensitive patient, lip injections, etc.)

The needle entry point (at least on the face) should still be anesthetized with a topical or local anaesthetic.

Page 23: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Mixing Lidocaine with Radiesse

Eliminates distortion of the treatment site from the local anesthetic.

I find that most of my midface injections can be done just with a topical anesthetic on the oral mucosa.

I now mix lidocaine with Radiesse for basically all of my injections.

Eliminates the immediately post injection ”burning” that some patients used to complain of.

Page 24: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Radiesse Mixing with Lidocaine

Why mix Radiesse with lidocaine?– Provide a less-painful alternative by eliminating the

pain of a block and reducing discomfort for areas that are not easily blocked

– Prevent tissue distortion that may be caused by injecting local anesthetics

– Adjust the cohesiveness of Radiesse to use it as a layering rather than a bulking filler

Page 25: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Mixing Lidocaine with Radiesse

0.15- 0.2 cc of 1 - 2% lidocaine with or without epinephrine is placed into an empty Radiesse 1.3cc syringe (A).

Syringe A is connected to a 1.3 cc syringe (B) of Radiesse using a 3 Way tap (or Luer lock to Luer lock connector).

The Radiesse contents are injected into syringe A and the mixture is then “swished” back and forth several times. 10 back and forth “swishes” are needed to obtain a homogeneous product.

The mixture of Radiesse and lidocaine is then advanced back into the 1.3 cc syringe.

Page 26: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Ailesbury Lidocaine Mixing Technique

1. 0.15 -0.2cc of 2% plain Xylocaine +/- adrenaline is introduced using a previous 1.3ml Radiesse syringe and a 3 way lock with another 1.3ml syringe

Page 27: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Similar US Lidocaine Mixing Technique

1. 0.15 cc of 2% plain Xylocaine or 1% Lidocaine + Adr is introduced using a luer lock-to-luer lock connector (Baxa) and a 1 cc or 3 cc syringe

Page 28: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Hand Volumisation

As the hands age there is a loss of subcutaneous tissue in the dorsum of the hands.

The hands become skeletonised with more prominent appearance of tendons and veins.

This can be a “giveaway” to the patient’s true age despite efforts to rejuvenate the face.

YOUNG OLD

Page 29: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Signs of Ageing Hand

Soft Tissue Atrophy

Pigmentation

Venous prominence

Tendon Show

Wrinkles

Page 30: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Radiesse for Hand Volumisation

Radiesse probably represents the best filler we currently have available for the dorsum of the hands.

Simpler, less invasive, and more natural results than fat transfer. 5 – 10 minute procedure with no anesthesia needed other than

mixing lidocaine (without adrenaline). Bolus injection into the subdermal areolar space. Massage Radiesse to distribute it evenly. Total Volume – 1.3 to 1.95 cc per hand

Page 31: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

PresentationContent

Page 32: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Radiesse in Hands

Before Immediately After1.3 cc

Page 33: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

Radiesse for Hand Volumisation

Before Immediately After1.3 cc

Mike Jasin, MD Tampa, FL

Page 34: Advanced Injectors Lecture BACD Regional Meeting London June 2008.

PresentationContent